CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,991,980
- in 20 filings, $60.0M under 10b5-1 plans
Net −$59,991,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 82 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-25 | Horn Margaret A Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) | −7,500 | 5,941 | ||
| 2023-10-24 | GOLDSMITH MARK A Director | Exercise or conversion | +35,000 | $0.49 | $17K | 384,332 |
| 2023-10-24 | GOLDSMITH MARK A Director | Exercise or conversion · Stock Option (Right to Buy) | −35,000 | 67,446 | ||
| 2023-10-23 | Anders Jack Chief Financial Officer | Exercise or conversion | +19,387 | $2.68 | $52K | 73,054 |
| 2023-10-23 | Anders Jack Chief Financial Officer | Exercise or conversion | +5,137 | $4.09 | $21K | 78,191 |
| 2023-10-23 | Anders Jack Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −19,387 | 22,814 | ||
| 2023-10-23 | Anders Jack Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,137 | 0 | ||
| 2023-10-16 | Horn Margaret A Chief Operating Officer | Exercise or conversion 10b5-1 | +25,000 | $4.09 | $102K | 121,960 |
| 2023-10-16 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −100 | $30.15 | $3K | 121,860 |
| 2023-10-16 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −500 | $31.96 | $16K | 121,360 |
| 2023-10-16 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −800 | $33.23 | $27K | 120,560 |
| 2023-10-16 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −23,200 | $34.02 | $789K | 97,360 |
| 2023-10-16 | Horn Margaret A Chief Operating Officer | Sale 10b5-1 | −400 | $35.00 | $14K | 96,960 |
| 2023-10-16 | Horn Margaret A Chief Operating Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −25,000 | 78,302 | ||
| 2023-10-11 | Kelsey Stephen Michael | Sale 10b5-1 | −16,667 | $29.05 | $484K | 273,721 |
| 2023-09-28 | Cislini Jeff General Counsel | Sale 10b5-1 | −1,798 | $28.10 | $51K | 40,215 |
| 2023-09-28 | Cislini Jeff General Counsel | Sale 10b5-1 | −202 | $29.06 | $6K | 40,013 |
| 2023-09-18 | Kelsey Stephen Michael | Sale | −2,060 | $31.31 | $64K | 290,388 |
| 2023-09-18 | GOLDSMITH MARK A Director | Sale | −8,054 | $31.31 | $252K | 349,332 |
| 2023-09-18 | Cislini Jeff General Counsel | Sale | −1,214 | $31.31 | $38K | 42,013 |
Page 30 of 39 · 775 trades